PAPA-ARTIS | Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial
01-01-2017
-30-09-2024
Projects overview
13 items found
LIVERHOPE | SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS
01-01-2017
-28-02-2023
ALIVER | Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)
01-01-2017
-31-01-2021
EURE-CART | EURopean Endeavour for Chimeric Antigen Receptor Therapies
01-01-2017
-30-06-2021
TreatER | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery
01-01-2017
-31-12-2020
KidsAP | The artificial pancreas in children aged 1 to 7 years with type 1 diabetes
01-01-2017
-31-12-2021
HIVACAR | Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection
01-01-2017
-30-06-2022
STIPED | Transcranial brain stimulation as innovative therapy for chronic pediatric neuropsychiatric disorder – STIPED
01-01-2017
-30-06-2022
WEAKID | Clinical validation of miniature wearable dialysis machine
01-01-2017
-30-06-2019
anTBiotic | AnTBiotic – progressing TB drug candidates to clinical proof of concept
01-01-2017
-30-06-2022
IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer
01-12-2017
-30-11-2022
PROOF | Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial
01-01-2017
-30-06-2023
IMMUNOSABR | Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer
01-01-2017
-31-12-2024